Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors
The term monoclonal B-cell lymphocytosis (MBL) describes the presence of a clonal B cell population with a count of less than 5 × 109/L and no symptoms or signs of disease. Based on the B cell count, MBL is further classified into 2 distinct subtypes: ‘low-count’ and ‘high-count’ MBL. High-count MBL...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/efa67e0fa42246998d881be6f07618f4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:efa67e0fa42246998d881be6f07618f4 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:efa67e0fa42246998d881be6f07618f42021-11-11T04:42:52ZUnderstanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors2234-943X10.3389/fonc.2021.769612https://doaj.org/article/efa67e0fa42246998d881be6f07618f42021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.769612/fullhttps://doaj.org/toc/2234-943XThe term monoclonal B-cell lymphocytosis (MBL) describes the presence of a clonal B cell population with a count of less than 5 × 109/L and no symptoms or signs of disease. Based on the B cell count, MBL is further classified into 2 distinct subtypes: ‘low-count’ and ‘high-count’ MBL. High-count MBL shares a series of biological and clinical features with chronic lymphocytic leukemia (CLL), at least of the indolent type, and evolves to CLL requiring treatment at a rate of 1-2% per year, whereas ‘low-count’ MBL seems to be distinct, likely representing an immunological rather than a pre-malignant condition. That notwithstanding, both subtypes of MBL can carry ‘CLL-specific’ genomic aberrations such as cytogenetic abnormalities and gene mutations, yet to a much lesser extent compared to CLL. These findings suggest that such aberrations are mostly relevant for disease progression rather than disease onset, indirectly pointing to microenvironmental drive as a key contributor to the emergence of MBL. Understanding microenvironmental interactions is therefore anticipated to elucidate MBL ontogeny and, most importantly, the relationship between MBL and CLL.Chrysi GaligalidouChrysi GaligalidouLaura Zaragoza-InfanteLaura Zaragoza-InfanteAnastasia IatrouAnastasia ChatzidimitriouAnastasia ChatzidimitriouKostas StamatopoulosKostas StamatopoulosAndreas AgathangelidisAndreas AgathangelidisFrontiers Media S.A.articlemonoclonal B cell lymphocytosis (MBL)chronic Lymphocutic Leukemia (CLL)geneticsimmunogeneticstumor microenvironmentontogenesisNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
monoclonal B cell lymphocytosis (MBL) chronic Lymphocutic Leukemia (CLL) genetics immunogenetics tumor microenvironment ontogenesis Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
monoclonal B cell lymphocytosis (MBL) chronic Lymphocutic Leukemia (CLL) genetics immunogenetics tumor microenvironment ontogenesis Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Chrysi Galigalidou Chrysi Galigalidou Laura Zaragoza-Infante Laura Zaragoza-Infante Anastasia Iatrou Anastasia Chatzidimitriou Anastasia Chatzidimitriou Kostas Stamatopoulos Kostas Stamatopoulos Andreas Agathangelidis Andreas Agathangelidis Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors |
description |
The term monoclonal B-cell lymphocytosis (MBL) describes the presence of a clonal B cell population with a count of less than 5 × 109/L and no symptoms or signs of disease. Based on the B cell count, MBL is further classified into 2 distinct subtypes: ‘low-count’ and ‘high-count’ MBL. High-count MBL shares a series of biological and clinical features with chronic lymphocytic leukemia (CLL), at least of the indolent type, and evolves to CLL requiring treatment at a rate of 1-2% per year, whereas ‘low-count’ MBL seems to be distinct, likely representing an immunological rather than a pre-malignant condition. That notwithstanding, both subtypes of MBL can carry ‘CLL-specific’ genomic aberrations such as cytogenetic abnormalities and gene mutations, yet to a much lesser extent compared to CLL. These findings suggest that such aberrations are mostly relevant for disease progression rather than disease onset, indirectly pointing to microenvironmental drive as a key contributor to the emergence of MBL. Understanding microenvironmental interactions is therefore anticipated to elucidate MBL ontogeny and, most importantly, the relationship between MBL and CLL. |
format |
article |
author |
Chrysi Galigalidou Chrysi Galigalidou Laura Zaragoza-Infante Laura Zaragoza-Infante Anastasia Iatrou Anastasia Chatzidimitriou Anastasia Chatzidimitriou Kostas Stamatopoulos Kostas Stamatopoulos Andreas Agathangelidis Andreas Agathangelidis |
author_facet |
Chrysi Galigalidou Chrysi Galigalidou Laura Zaragoza-Infante Laura Zaragoza-Infante Anastasia Iatrou Anastasia Chatzidimitriou Anastasia Chatzidimitriou Kostas Stamatopoulos Kostas Stamatopoulos Andreas Agathangelidis Andreas Agathangelidis |
author_sort |
Chrysi Galigalidou |
title |
Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors |
title_short |
Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors |
title_full |
Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors |
title_fullStr |
Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors |
title_full_unstemmed |
Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors |
title_sort |
understanding monoclonal b cell lymphocytosis: an interplay of genetic and microenvironmental factors |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/efa67e0fa42246998d881be6f07618f4 |
work_keys_str_mv |
AT chrysigaligalidou understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors AT chrysigaligalidou understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors AT laurazaragozainfante understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors AT laurazaragozainfante understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors AT anastasiaiatrou understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors AT anastasiachatzidimitriou understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors AT anastasiachatzidimitriou understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors AT kostasstamatopoulos understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors AT kostasstamatopoulos understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors AT andreasagathangelidis understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors AT andreasagathangelidis understandingmonoclonalbcelllymphocytosisaninterplayofgeneticandmicroenvironmentalfactors |
_version_ |
1718439642889453568 |